KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Non-Current Debt (2016 - 2026)

Medtronic's Non-Current Debt history spans 13 years, with the latest figure at $27.9 billion for Q1 2026.

  • For Q1 2026, Non-Current Debt rose 16.24% year-over-year to $27.9 billion; the TTM value through Jan 2026 reached $27.9 billion, up 16.24%, while the annual FY2025 figure was $25.6 billion, 7.15% up from the prior year.
  • Non-Current Debt for Q1 2026 was $27.9 billion at Medtronic, up from $27.7 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $27.9 billion in Q1 2026 and bottomed at $17.5 billion in Q3 2022.
  • The 5-year median for Non-Current Debt is $24.3 billion (2022), against an average of $24.0 billion.
  • The largest annual shift saw Non-Current Debt tumbled 32.66% in 2022 before it soared 39.94% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $20.8 billion in 2022, then increased by 14.4% to $23.7 billion in 2023, then rose by 3.65% to $24.6 billion in 2024, then rose by 12.49% to $27.7 billion in 2025, then grew by 0.72% to $27.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Non-Current Debt are $27.9 billion (Q1 2026), $27.7 billion (Q4 2025), and $26.2 billion (Q3 2025).